CERO THERAPEUTICS HOLDINGS, INC. |
Interim Chairman and CEO, Director |
Series A Convertible Preferred Stock |
0 |
$0 |
$1,000.00 |
Sep 25, 2024 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Interim Chairman and CEO, Director |
Common Stock |
5.79M |
|
|
Sep 25, 2024 |
Direct |
PHOENIX BIOTECH ACQUISITION CORP. |
Interim Chairman and CEO, Director |
Warrants |
5K |
|
|
Feb 14, 2024 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Interim Chairman and CEO, Director |
Common Stock |
3.6K |
|
|
Sep 25, 2024 |
By Spouse |
eFFECTOR Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
800 |
|
|
Jun 13, 2024 |
Direct |
CERO THERAPEUTICS HOLDINGS, INC. |
Interim Chairman and CEO, Director |
Stock Option (Right to Buy) |
0 |
|
|
Sep 30, 2024 |
Direct |
PHOENIX BIOTECH ACQUISITION CORP. |
Interim Chairman and CEO, Director |
Convertible Promissory Note |
0 |
|
|
Feb 14, 2024 |
By Phoenix Biotech Sponsor, LLC |
PHOENIX BIOTECH ACQUISITION CORP. |
Interim Chairman and CEO, Director |
Warrants |
0 |
|
|
Feb 14, 2024 |
By Phoenix Biotech Sponsor, LLC |